drugset / Trial / NCT02101125

Drug Interaction Study With Rosuvastatin

NCT02101125

Phase 1 Completed 26 enrolled Bristol-Myers Squibb
Parallel-groupOpen-label

Summary

The purpose of this study is to evaluate the effect of concomitant administration of BMS-986020 on the single dose Pharmacokinetics (PK) of Rosuvastatin in healthy subjects.

Timeline

Start
2014-03
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986020 Small molecule Oral
Subject Rosuvastatin Small molecule

Indications

No indication recorded.